{"denoms":[{"counts":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"51"},{"groupId":"BG002","value":"18"},{"groupId":"BG003","value":"101"}],"units":"Participants"}],"groups":[{"description":"Participants randomized to receive adalimumab 2.4 mg/kg (maximum dose of 160 mg) at Baseline and matching placebo at Week 1, 1.2 mg/kg (maximum dose of 80 mg) at Week 2, followed by 0.6 mg/kg (maximum dose of 40 mg) at Week 4 and Week 6.","id":"BG000","title":"Integrated Study (Main + Japan Sub- Study): I-SD"},{"description":"Participants randomized to receive adalimumab 2.4 mg/kg (maximum dose of 160 mg) at Baseline and at Week 1, 1.2 mg/kg (maximum dose of 80 mg) at Week 2, followed by 0.6 mg/kg (maximum dose of 40 mg) at Week 4 and Week 6.","id":"BG001","title":"Integrated Study (Main + Japan Sub- Study): I-HD"},{"description":"(After Amendment 4) participants assigned to open-label adalimumab 2.4 mg/kg (maximum dose of 160 mg) at Baseline and at Week 1, 1.2 mg/kg (maximum dose of 80 mg) at Week 2, followed by 0.6 mg/kg (maximum dose of 40 mg) at Week 4 and Week 6.","id":"BG002","title":"Integrated Study (Main + Japan Sub- Study): I-HD-OL"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"2.66","value":"14.7"},{"groupId":"BG001","spread":"3.06","value":"13.8"},{"groupId":"BG002","spread":"2.82","value":"13.8"},{"groupId":"BG003","spread":"2.90","value":"14.1"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"13"},{"groupId":"BG003","value":"51"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"50"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"45"},{"groupId":"BG002","value":"15"},{"groupId":"BG003","value":"88"}]}],"title":"White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"3"}]}],"title":"Black"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"9"}]}],"title":"Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"}]}],"title":"Multiple"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"4"}]}],"title":"Hispanic or Latino"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"8"}]}],"title":"Japanese"},{"categories":[{"measurements":[{"groupId":"BG000","value":"29"},{"groupId":"BG001","value":"45"},{"groupId":"BG002","value":"15"},{"groupId":"BG003","value":"89"}]}],"title":"No Ethnicity"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"1.22","value":"7.8"},{"groupId":"BG001","spread":"1.25","value":"7.7"},{"groupId":"BG002","spread":"1.09","value":"7.7"},{"groupId":"BG003","spread":"1.20","value":"7.8"}]}]}],"description":"The Mayo score is a tool designed to measure disease activity for ulcerative colitis. The FMS ranges from 0 (normal or inactive disease) to 12 (severe disease) and is calculated as the sum of 4 subscores (stool frequency, rectal bleeding, endoscopy, and physician's global assessment), each of which ranges from 0 (normal) to 3 (severe disease).","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Full Mayo Score (FMS)","unitOfMeasure":"score on a scale"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"1.14","value":"5.7"},{"groupId":"BG001","spread":"1.24","value":"5.5"},{"groupId":"BG002","spread":"1.06","value":"5.5"},{"groupId":"BG003","spread":"1.17","value":"5.6"}]}]}],"description":"The PMS (Mayo score without endoscopy) ranges from 0 (normal or inactive disease) to 9 (severe disease) and is calculated as the sum of 3 subscores (stool frequency, rectal bleeding and physician's global assessment), each of which ranges from 0 (normal) to 3 (severe disease).","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Partial Mayo Score (PMS)","unitOfMeasure":"score on a scale"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"0.34","value":"2.1"},{"groupId":"BG001","spread":"0.40","value":"2.2"},{"groupId":"BG002","spread":"0.43","value":"2.2"},{"groupId":"BG003","spread":"0.38","value":"2.2"}]}]}],"description":"The endoscopy subscore of the FMS ranges from 0 (normal) to 3 (severe disease).","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Endoscopy Subscore","unitOfMeasure":"score on a scale"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"0.93","value":"1.4"},{"groupId":"BG001","spread":"0.88","value":"1.5"},{"groupId":"BG002","spread":"0.97","value":"1.4"},{"groupId":"BG003","spread":"0.91","value":"1.5"}]}]}],"description":"The rectal bleeding subscore of the FMS ranges from 0 (normal) to 3 (severe disease).","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Rectal Bleeding Subscore","unitOfMeasure":"score on a scale"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"0.40","value":"2.2"},{"groupId":"BG001","spread":"0.43","value":"2.2"},{"groupId":"BG002","spread":"0.38","value":"2.2"},{"groupId":"BG003","spread":"0.41","value":"2.2"}]}]}],"description":"The physicians global assessment subscore of the FMS ranges from 0 (normal) to 3 (severe disease).","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Physicians Global Assessment Subscore","unitOfMeasure":"score on a scale"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"0.78","value":"2.1"},{"groupId":"BG001","spread":"0.88","value":"1.8"},{"groupId":"BG002","spread":"0.73","value":"1.9"},{"groupId":"BG003","spread":"0.83","value":"1.9"}]}]}],"description":"The stool frequency subscore of the FMS ranges from 0 (normal) to 3 (severe disease).","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Stool Frequency Subscore","unitOfMeasure":"score on a scale"}]}